| Nuvalent Inc | 17 248 450 | 1,8 Md $ | |
| Cogent Biosciences Inc | 9 043 903 | 348,1 M $ | |
| Praxis Precision Medicines Inc | 963 351 | 310,4 M $ | |
| Viatris Inc | 20 206 170 | 273 M $ | |
| United Therapeutics Corp | 457 000 | 271 M $ | |
| Revolution Medicines Inc | 2 297 000 | 223,4 M $ | |
| Celcuity Inc | 1 714 000 | 195,6 M $ | |
| Centene Corp | 5 917 091 | 193,7 M $ | |
| Larimar Therapeutics Inc | 35 606 974 | 160,2 M $ | |
| Brookdale Senior Living Inc | 11 637 032 | 159,2 M $ | |
| Vera Therapeutics Inc | 3 722 100 | 149,7 M $ | |
| Ionis Pharmaceuticals Inc | 1 979 669 | 148,7 M $ | |
| BioCryst Pharmaceuticals Inc | 15 038 000 | 143,2 M $ | |
| Inspire Medical Systems Inc | 2 703 238 | 139,4 M $ | |
| LEGEND BIOTECH CORP | 7 687 638 | 139,1 M $ | |
| AdaptHealth Corp | 11 477 730 | 136,6 M $ | |
| Acadia Healthcare Co Inc | 4 520 000 | 105,7 M $ | |
| Arrowhead Pharmaceuticals Inc | 1 573 297 | 98,6 M $ | |
| Catalyst Pharmaceuticals Inc | 3 943 600 | 97,6 M $ | |
| Indivior Pharmaceuticals Inc | 3 097 790 | 94,4 M $ | |
| Syndax Pharmaceuticals Inc | 3 779 900 | 88,3 M $ | |
| Tango Therapeutics Inc | 4 146 813 | 86,8 M $ | |
| Dianthus Therapeutics Inc | 1 019 813 | 85,6 M $ | |
| Pfizer Inc | 3 040 000 | 85,4 M $ | |
| Neurocrine Biosciences Inc | 610 000 | 80,4 M $ | |
| Day One Biopharmaceuticals Inc | 3 723 131 | 79,8 M $ | |
| Savara Inc | 13 569 000 | 74,1 M $ | |
| Enhabit Inc | 4 747 746 | 66,9 M $ | |
| Genmab A/S | 2 462 000 | 66,1 M $ | |
| Bio-Rad Laboratories Inc | 226 070 | 63 M $ | |
| Lantheus Holdings Inc | 827 999 | 62,8 M $ | |
| ARS Pharmaceuticals Inc | 7 503 812 | 60,3 M $ | |
| Stoke Therapeutics Inc | 1 823 500 | 59,4 M $ | |
| Envista Holdings Corp | 2 210 100 | 56,1 M $ | |
| Ideaya Biosciences Inc | 1 530 008 | 51 M $ | |
| Belite Bio Inc | 304 013 | 48,5 M $ | |
| BioMarin Pharmaceutical Inc | 851 556 | 48,1 M $ | |
| Kymera Therapeutics Inc | 561 170 | 46,7 M $ | |
| Certara Inc | 7 808 605 | 44,5 M $ | |
| BridgeBio Oncology Therapeutics Inc | 4 885 446 | 43,7 M $ | |
| Disc Medicine Inc | 657 000 | 42 M $ | |
| Sionna Therapeutics Inc | 970 590 | 38,9 M $ | |
| CareDx Inc | 2 191 000 | 38 M $ | |
| Structure Therapeutics Inc | 767 993 | 37 M $ | |
| Veracyte Inc | 726 000 | 23,4 M $ | |
| Alnylam Pharmaceuticals Inc | 67 935 | 22,5 M $ | |
| Embecta Corp | 2 534 961 | 22,4 M $ | |
| Tyra Biosciences Inc | 549 000 | 21 M $ | |
| Foghorn Therapeutics Inc | 4 394 367 | 21 M $ | |
| Compass Therapeutics Inc | 3 606 000 | 19,1 M $ | |
| Monopar Therapeutics Inc | 323 745 | 17,7 M $ | |
| Kyverna Therapeutics Inc | 2 000 000 | 17,3 M $ | |
| SpyGlass Pharma Inc | 550 000 | 14,3 M $ | |
| Beta Bionics Inc | 1 324 000 | 13,3 M $ | |
| Taysha Gene Therapies Inc | 2 722 165 | 12,2 M $ | |
| Oncology Institute Inc/The | 3 360 052 | 10,3 M $ | |
| Cullinan Therapeutics Inc | 386 169 | 5,5 M $ | |
| Annexon Inc | 583 913 | 3,2 M $ | |
| Alector Inc | 1 055 192 | 2,3 M $ | |
| Edwards Lifesciences Corp | 13 702 | 1,1 M $ | |
| VeraDermics Inc | 5 000 | 315,8 k $ | |
| Humana Inc | 917 | 159 k $ | |
| PMV Pharmaceuticals Inc | 8 790 | 10,9 k $ | |
| Myriad Genetics Inc | 505 | 2,3 k $ | |